Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

Revvity has unveiled new high-impact discovery platforms, including the Opera Phenix OptIQ high-content screening system, EnVision Nexus One multimode plate reader, and AssayMate workstation, designed to accelerate drug discovery workflows. These solutions support discovery programs from early screening through data-driven decision making and integrate automation, trusted assay technologies, and AI-driven imaging to help customers accelerate results.